Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

J Bousquet^{1

2

3}, I Agache⁴, M R Aliberti⁵, R Angles⁶, I Annesi-Maesano^{7

8}, J M Anto^{9

10

11}, S Arnavielhe¹², E Asayag¹³, E Bacci¹⁴, A Bedbrook¹, C Bachert¹⁵, I Baroni¹⁶, B A Barreto¹⁷, M Bedolla-Barajas¹⁸, K C Bergmann^{19

20}, L Bertorello¹⁴, M Bewick²¹, T Bieber²², S Birov²³, C Bindslev-Jensen²⁴, A Blua²⁵, M Bochenska Marciniak²⁶, I Bogus-Buczynska²⁶, S Bosnic-Anticevich²⁷, I Bosse²⁸, R Bourret²⁹, C Bucca³⁰, R Buonaiuto³¹, M T Burguete Cabanas³², D Caillaud³³, D P Caimmi³⁴, D Caiazza³¹, P Camargos³⁵, G Canfora³⁶, V Cardona³⁷, A M Carriazo³⁸, C Cartier³⁹, G Castellano⁴⁰, N H Chavannes⁴¹, L Cecci⁴², M M Ciaravolo⁴³, C Cingi⁴⁴, A Ciceran⁴⁵, L Colas⁴⁶, E Colgan⁴⁷, J Coll⁶, D Conforti⁴⁸, J Correia de Sousa⁴⁹, R M Cortés-Grimaldo⁵⁰, F Corti⁵¹, E Costa⁵², A L Courbis⁵³, E Cousein⁵⁴, A A Cruz^{55

56}, A Custovic⁵⁷, B Cvetkovski²⁷, C Dario⁵⁸, J da Silva⁵⁹, Y Dauvilliers⁶⁰, F De Blay⁶¹, T Dedeu⁶², G De Feo⁶³, B De Martino⁶⁴, P Demoly³⁴, G De Vries⁶⁵, S Di Capua Ercolano⁶⁶, N Di Carluccio³¹, M Doulapsi⁶⁷, G Dray⁵³, R Dubakiene⁶⁸, E Eller²⁴, R Emuzyte⁶⁹, J G Espinoza-Contreras⁷⁰, A Estrada-Cardona⁷¹, J Farrell⁴⁷, A Farsi⁴², J Ferrero⁷², W J Fokkens⁷³, J Fonseca^{74

75}, J F Fontaine⁷⁶, S Forti⁴⁸, J L Gálvez-Romero⁷⁷, C I García-Cobas⁷⁸, M H Garcia Cruz⁷⁹, B Gemicioğlu⁸⁰, R Gerth van Wijk⁸¹, M Guidacci⁸², J Gómez-Vera⁸³, N A Guldemond⁸⁴, Z Gutter⁸⁵, T Haahtela⁸⁶, J Hajjam⁸⁷, P W Hellings⁸⁸, L Hernández-Velázquez⁸⁹, M Illario⁹⁰, J C Ivancevich⁹¹, E Jares⁹², G Joos⁹³, J Just^{94

95}, O Kalayci⁹⁶, A F Kalyoncu⁹⁷, J Karjalainen⁹⁸, T Keil⁹⁹, N Khaltaev¹⁰⁰, L Klimek¹⁰¹, V Kritikos²⁷, I Kull¹⁰², P Kuna²⁶, V Kvedariene¹⁰³, V Kolek¹⁰⁴, E Krzych-Fałta¹⁰⁵, M Kupczyk²⁶, P Lacwik²⁶, S La Grutta¹⁰⁶, D Larenas-Linnemann¹⁰⁷, D Laune¹², D Lauri¹⁰⁸, J Lavrut¹⁰⁹, M Lessa¹¹⁰, G Levato¹¹¹, L Lewis¹¹², I Lieten¹¹³, A Lipiec¹⁰⁵, R Louis¹¹⁴, J A Luna-Pech¹¹⁵, A Magnan⁴⁶, J Malva^{116

117}, J F Maspero¹¹⁸, J J Matta-Campos¹¹⁹, O Mayora⁴⁸, M A Medina-Ávalos¹²⁰, E Melén¹²¹, E Menditto¹²², J Millot-Keurinck¹²³, G Moda¹²⁴, M Morais-Almeida¹²⁵, R Mösges¹²⁶, A Mota-Pinto^{117

127

128}, J Mullol¹²⁹, A Muraro¹³⁰, R Murray¹³¹, M Noguès¹²³, M Nalin¹⁶, L Napoli¹³², H Neffen¹³³, R E O'Hehir¹³⁴, G L Onorato¹, S Palkonen¹³⁵, N G Papadopoulos^{136

137}, G Passalacqua¹³⁸, J L Pépin¹³⁹, A M Pereira¹⁴⁰, M Persico¹⁴¹, O Pfaar^{142

101}, A C Pozzi¹⁴³, E Prokopakis⁶⁷, B Pugin⁸⁸, F Raciborski¹⁰⁵, J Rimmer²⁷, J A Rizzo¹⁴⁴, C Robalo-Cordeiro¹⁴⁵, M Rodríguez-González¹⁴⁶, G Rolla¹²⁴, R E Roller-Wirnsberger¹⁴⁷, A Romano^{148

149}, M Romano¹⁶, M R Romano⁵, J Salimäki¹⁵⁰, B Samolinski¹⁰⁵, F S Serpa¹⁵¹, S Shamai¹²⁶, M Sierra⁶, M Sova¹⁵², M Sorlini¹⁵³, C Stellato⁶³, R Stelmach¹⁵⁴, T Strandberg¹⁵⁵, V Stroetmann²³, R Stukas¹⁵⁶, A Szylling¹⁰⁵, R Tan²⁷, V Tibaldi¹²⁴, A Todo-Bom¹⁵⁷, S Toppila-Salmi⁸⁶, P Tomazic¹⁵⁸, U Trama¹⁵⁹, M Triggiani⁶³, A Valero¹⁶⁰, E Valovirta^{161

162}, A Valiulis^{163

164}, M van Eerd⁶⁵, T Vasankari¹⁶⁵, A Vatrella⁶³, M T Ventura¹⁶⁶, M T Verissimo^{116

117}, F Viart³⁹, S Williams¹⁶⁷, M Wagenmann¹⁶⁸, C Wanscher¹⁶⁹, M Westman¹⁷⁰, M Wickman¹²¹, I Young¹⁷¹, A Yorgancioglu¹⁷², E Zernotti¹⁷³, T Zuberbier^{19

20}, A Zurkuhlen¹⁷⁴, B De Oliviera¹⁷⁵, A Senn¹⁷⁵

Affiliations

¹ MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
² VIMA, INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France.
³ Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
⁴ Faculty of Medicine, Transylvania University, Brasov, Romania.
⁵ Municipality of Salerno, Salerno, Italy.
⁶ Innovación y nuevas tecnologías, Salud Sector sanitario de Barbastro, Barbastro, Spain.
⁷ EPAR U707 INSERM, Paris, France.
⁸ EPAR UMR-S UPMC, Paris VI, Paris, France.
⁹ ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
¹⁰ IMIM (Hospital del Mar Research Institute), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
¹¹ CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
¹² Kyomed, Montpellier, France.
¹³ Argentine Society of Allergy and Immunopathology, Buenos Aires, Argentina.
¹⁴ Regione Liguria, Genoa, Italy.
¹⁵ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
¹⁶ Telbios SRL, Milan, Italy.
¹⁷ Alergologo, Belem, Brazil.
¹⁸ Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalarara, Mexico.
¹⁹ Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
²⁰ Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
²¹ iQ4U Consultants Ltd, London, UK.
²² Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
²³ Empirica Communication and Technology Research, Bonn, Germany.
²⁴ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
²⁵ Argentine Association of Respiratory Medicine, Buenos Aires, Argentina.
²⁶ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
²⁷ Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia.
²⁸ Allergist, La Rochelle, France.
²⁹ Centre Hospitalier Valenciennes, Valenciennes, France.
³⁰ Chief of the University Pneumology Unit- AOU Molinette, Hospital City of Health and Science of Torino, Torino, Italy.
³¹ Pharmacist of COFASER - Consorzio Farmacie Servizi-Salerno, Salerno, Italy.
³² Centro Médico Zambrano Hellion, Monterrey, Mexico.
³³ Service de pneumologie, CHU et université d'Auvergne, Clermont-Ferrand, France.
³⁴ Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
³⁵ Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
³⁶ Mayor of Sarno and President of Salerno Province, Anesthesiology Service, Sarno "Martiri del Villa Malta" Hospital, Sarno, Italy.
³⁷ S. Allergologia, S. Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
³⁸ Regional Ministry of Health of Andalusia, Seville, Spain.
³⁹ ASA - Advanced Solutions Accelerator, Clapiers, France.
⁴⁰ Celentano Pharmacy, Massa Lubrense, Italy.
⁴¹ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
⁴² S.O.S Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
⁴³ Specialist Social Worker, Sorrento, Italy.
⁴⁴ ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
⁴⁵ Argentine Federation of Otorhinolaryngology Societies, Buenos Aires, Argentina.
⁴⁶ Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
⁴⁷ Department of Health, Social Services and Public Safety, Belfast, UK.
⁴⁸ Fondazione Bruno Kessler (FBK), Trento, Italy.
⁴⁹ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
⁵⁰ Alergologa, Guadalarara, Mexico.
⁵¹ FIMMG (Federazione Italiana Medici di Medicina Generale), Milan, Italy.
⁵² UCIBIO, REQYULTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), Porto, Portugal.
⁵³ Ecole des Mines, Alès, France.
⁵⁴ Vice Président de la CME - Centre Hospitalier, Valenciennes, France.
⁵⁵ ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
⁵⁶ GARD/WHO Executive Committee and Federal University of Bahia, Bahia, Brazil.
⁵⁷ Department of Pediatric, Imperial College London, London, UK.
⁵⁸ Azienda Provinciale per i Servizi Sanitari di Trento (APSS-Trento), Trento, Italy.
⁵⁹ Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil.
⁶⁰ Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Inserm U1061, Montpellier, France.
⁶¹ Allergy Division, Chest Disease Department, University Hospital of Strasbourg, Strasbourg, France.
⁶² AQuAS, Barcelona, Spain & EUREGHA, European Regional and Local Health Association, Brussels, Belgium.
⁶³ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
⁶⁴ Social Workers Coordinator, Sorrento, Italy.
⁶⁵ Peercode DV, Gerdermalsen, The Netherlands.
⁶⁶ Farmacie Dei Golfi Group, Massa Lubrense, Italy.
⁶⁷ Department of Otolaryngology, University of Crete School of Medicine, Heraklion, Greece.
⁶⁸ Medical Faculty, Vilnius University, Vilnius, Lithuania.
⁶⁹ Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
⁷⁰ University of Aguascalientes, Chihuaha, Mexico.
⁷¹ Alergologo, Playa del Carmen, Mexico.
⁷² Andalusian Agency for Healthcare Quality, Seville, Spain.
⁷³ Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
⁷⁴ Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
⁷⁵ Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
⁷⁶ Allergist, Reims, France.
⁷⁷ Regional Hospital of ISSSTE, Puebla, Mexico.
⁷⁸ Alergologo, Guadalarara, Mexico.
⁷⁹ Allergy Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico.
⁸⁰ Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
⁸¹ Department of Internal Medicine, Section of Allergology, Erasmus MC, Rotterdam, The Netherlands.
⁸² Member of the Brazilian Society of Pediatrics and Society of Immunization, Representative of GINA (Global Initiative Against Asthma), Brasilia, Brazil.
⁸³ Allergy Clinic, Hospital Regional del ISSSTE 'Lic. López Mateos', Mexico City, Mexico.
⁸⁴ Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
⁸⁵ University Hospital Olomouc - National eHealth Centre, Olomouk, Czech Republic.
⁸⁶ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
⁸⁷ Centich: centre d'expertise national des technologies de l'information et de la communication pour l'autonomie, Gérontopôle autonomie longévité des Pays de la Loire, Conseil régional des Pays de la Loire, Centre d'expertise Partenariat Européen d'Innovation pour un vieillissement actif et en bonne santé, Nantes, France.
⁸⁸ Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
⁸⁹ Alergologo, Ensenada, Mexico.
⁹⁰ Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
⁹¹ Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
⁹² Libra Foundation, Buenos Aires, Argentina.
⁹³ Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
⁹⁴ Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau (APHP, Paris), Paris, France.
⁹⁵ Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
⁹⁶ Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey.
⁹⁷ Immunology and Allergy Division, Department of Chest Diseases, School of Medicine, Hacettepe University, Ankara, Turkey.
⁹⁸ Allergy Centre, Tampere University Hospital, Tampere, Finland.
⁹⁹ Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
¹⁰⁰ GARD, Geneva, Switzerland.
¹⁰¹ Center for Rhinology and Allergology, Wiesbaden, Germany.
¹⁰² Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
¹⁰³ Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
¹⁰⁴ Department of Respiratory Medicine, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic.
¹⁰⁵ Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
¹⁰⁶ Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy.
¹⁰⁷ Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México City, Mexico.
¹⁰⁸ Presidente CMMC, Milano, Italy.
¹⁰⁹ Head of the Allergy Department of Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina.
¹¹⁰ Faculdade de Medicina da Universidade Federal da Bahia, Salvador de Bahia, Brazil.
¹¹¹ Sifmed, Milano, Italy.
¹¹² Promotor B3 Action GRoup EIP on AHA and Senior Fellow, International Foundation for Integreted Care, Aberystwyth, UK.
¹¹³ Tech Life Valley, Diepenbeek, Belgium.
¹¹⁴ Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
¹¹⁵ University of Guadalajara, Guadalara, Mexico.
¹¹⁶ Faculty of Medicine, Institute of Biomedical Imaging and Life Sciences (IBILI), University of Coimbra, Coimbra, Portugal.
¹¹⁷ Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
¹¹⁸ Argentine Association of Allergy and Clinical Immunology, Buenos Aires, Argentina.
¹¹⁹ Hospital Regional Siglo XXI, Mexico City, Mexico.
¹²⁰ Alergologo, Veracruz, Mexico.
¹²¹ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹²² CIRFF, Federico II University, Naples, Italy.
¹²³ Caisse d'assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR), Montpellier, France.
¹²⁴ Regione Piemonte, Torino, Italy.
¹²⁵ Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal.
¹²⁶ Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
¹²⁷ Laboratory of General Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
¹²⁸ Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
¹²⁹ Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
¹³⁰ Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy.
¹³¹ MedScript Ltd, Dundalk, Co. Louth, Ireland.
¹³² Consortium of Pharmacies and Services COSAFER, Salerno, Italy.
¹³³ Head of Respiratory Medicine, Alassia Children's Hospital, Center for Allergy and Immunology, Santa Fe, Argentina.
¹³⁴ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic., Australia.
¹³⁵ EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
¹³⁶ Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
¹³⁷ Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
¹³⁸ Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, Genoa, Italy.
¹³⁹ Department of Pneumology, CHU Grenoble, Grenoble, France.
¹⁴⁰ Allergy Unit, CUF-Porto Hospital and Institute, Center for Research in Health Technologies and Information Systems, CINTESIS, Universidade do Porto, Porto, Portugal.
¹⁴¹ Sociologist, Municipality, Sorrento, Italy.
¹⁴² Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
¹⁴³ Vice-Presidente of IML, Milano, Italy.
¹⁴⁴ Alergista, Recife, Brazil.
¹⁴⁵ Centre of Pneumology, Coimbra University Hospital, Coimbra, Portugal.
¹⁴⁶ Alergologo, Mexico City, Mexico.
¹⁴⁷ Medical University of Graz, Graz, Austria.
¹⁴⁸ Allergy Unit, Presidio Columbus, Rome, Catholic University of Sacred Heart, Rome, Italy.
¹⁴⁹ IRCCS Oasi Maria S.S., Troina, Italy.
¹⁵⁰ Association of Finnish Pharmacists, Helsinki, Finland.
¹⁵¹ Allergist, Vitoria, Brazil.
¹⁵² Departement of Internal Medicine, University Hospital, Olomouc, Czech Republic.
¹⁵³ IML (Lombardy Medical Initiative), Bergamo, Italy.
¹⁵⁴ Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
¹⁵⁵ Center for Life Course Health Research, Helsinki University Hospital, Helsinki University, University of Oulu, Oulu, Finland.
¹⁵⁶ Public Health Institute of Vilnius University, Vilnius, Lithuania.
¹⁵⁷ Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
¹⁵⁸ Department of ENT, Medical University of Graz, Graz, Austria.
¹⁵⁹ Division on Pharmacy and Devices Policy, Campania Region, Naples, Italy.
¹⁶⁰ Pneumology and Allergy Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
¹⁶¹ Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.
¹⁶² Allergy Clinic, Terveystalo, Turku, Finland.
¹⁶³ Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania.
¹⁶⁴ European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
¹⁶⁵ FILHA, Finnish Lung Association, Helsinki, Finland.
¹⁶⁶ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
¹⁶⁷ International Primary Care Respiratory Group IPCRG, Aberdeen, UK.
¹⁶⁸ Department of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
¹⁶⁹ EIP on AHA Coordinator, Region of Southern Denmark, Odense, Denmark.
¹⁷⁰ Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet and Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden.
¹⁷¹ Queen's University, Belfast, UK.
¹⁷² Celal Bayar University Department of Pulmonology, GARD Executive Committee, Manisa, Turkey.
¹⁷³ Universidad Católica de Córdoba, Córdoba, Argentina.
¹⁷⁴ Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
¹⁷⁵ EC-CNECT-H2, European Commission, Brussels, Belgium.

PMID: 28600902
DOI: 10.1111/all.13218

Free article

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

J Bousquet et al. Allergy. 2018 Jan.

Free article

. 2018 Jan;73(1):77-92.

doi: 10.1111/all.13218. Epub 2017 Aug 24.

Authors

Affiliations

¹ MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
² VIMA, INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France.
³ Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
⁴ Faculty of Medicine, Transylvania University, Brasov, Romania.
⁵ Municipality of Salerno, Salerno, Italy.
⁶ Innovación y nuevas tecnologías, Salud Sector sanitario de Barbastro, Barbastro, Spain.
⁷ EPAR U707 INSERM, Paris, France.
⁸ EPAR UMR-S UPMC, Paris VI, Paris, France.
⁹ ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
¹⁰ IMIM (Hospital del Mar Research Institute), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
¹¹ CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
¹² Kyomed, Montpellier, France.
¹³ Argentine Society of Allergy and Immunopathology, Buenos Aires, Argentina.
¹⁴ Regione Liguria, Genoa, Italy.
¹⁵ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
¹⁶ Telbios SRL, Milan, Italy.
¹⁷ Alergologo, Belem, Brazil.
¹⁸ Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalarara, Mexico.
¹⁹ Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
²⁰ Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
²¹ iQ4U Consultants Ltd, London, UK.
²² Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
²³ Empirica Communication and Technology Research, Bonn, Germany.
²⁴ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
²⁵ Argentine Association of Respiratory Medicine, Buenos Aires, Argentina.
²⁶ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
²⁷ Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia.
²⁸ Allergist, La Rochelle, France.
²⁹ Centre Hospitalier Valenciennes, Valenciennes, France.
³⁰ Chief of the University Pneumology Unit- AOU Molinette, Hospital City of Health and Science of Torino, Torino, Italy.
³¹ Pharmacist of COFASER - Consorzio Farmacie Servizi-Salerno, Salerno, Italy.
³² Centro Médico Zambrano Hellion, Monterrey, Mexico.
³³ Service de pneumologie, CHU et université d'Auvergne, Clermont-Ferrand, France.
³⁴ Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
³⁵ Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
³⁶ Mayor of Sarno and President of Salerno Province, Anesthesiology Service, Sarno "Martiri del Villa Malta" Hospital, Sarno, Italy.
³⁷ S. Allergologia, S. Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
³⁸ Regional Ministry of Health of Andalusia, Seville, Spain.
³⁹ ASA - Advanced Solutions Accelerator, Clapiers, France.
⁴⁰ Celentano Pharmacy, Massa Lubrense, Italy.
⁴¹ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
⁴² S.O.S Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
⁴³ Specialist Social Worker, Sorrento, Italy.
⁴⁴ ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
⁴⁵ Argentine Federation of Otorhinolaryngology Societies, Buenos Aires, Argentina.
⁴⁶ Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
⁴⁷ Department of Health, Social Services and Public Safety, Belfast, UK.
⁴⁸ Fondazione Bruno Kessler (FBK), Trento, Italy.
⁴⁹ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
⁵⁰ Alergologa, Guadalarara, Mexico.
⁵¹ FIMMG (Federazione Italiana Medici di Medicina Generale), Milan, Italy.
⁵² UCIBIO, REQYULTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), Porto, Portugal.
⁵³ Ecole des Mines, Alès, France.
⁵⁴ Vice Président de la CME - Centre Hospitalier, Valenciennes, France.
⁵⁵ ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
⁵⁶ GARD/WHO Executive Committee and Federal University of Bahia, Bahia, Brazil.
⁵⁷ Department of Pediatric, Imperial College London, London, UK.
⁵⁸ Azienda Provinciale per i Servizi Sanitari di Trento (APSS-Trento), Trento, Italy.
⁵⁹ Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil.
⁶⁰ Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Inserm U1061, Montpellier, France.
⁶¹ Allergy Division, Chest Disease Department, University Hospital of Strasbourg, Strasbourg, France.
⁶² AQuAS, Barcelona, Spain & EUREGHA, European Regional and Local Health Association, Brussels, Belgium.
⁶³ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
⁶⁴ Social Workers Coordinator, Sorrento, Italy.
⁶⁵ Peercode DV, Gerdermalsen, The Netherlands.
⁶⁶ Farmacie Dei Golfi Group, Massa Lubrense, Italy.
⁶⁷ Department of Otolaryngology, University of Crete School of Medicine, Heraklion, Greece.
⁶⁸ Medical Faculty, Vilnius University, Vilnius, Lithuania.
⁶⁹ Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
⁷⁰ University of Aguascalientes, Chihuaha, Mexico.
⁷¹ Alergologo, Playa del Carmen, Mexico.
⁷² Andalusian Agency for Healthcare Quality, Seville, Spain.
⁷³ Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
⁷⁴ Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
⁷⁵ Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
⁷⁶ Allergist, Reims, France.
⁷⁷ Regional Hospital of ISSSTE, Puebla, Mexico.
⁷⁸ Alergologo, Guadalarara, Mexico.
⁷⁹ Allergy Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico.
⁸⁰ Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
⁸¹ Department of Internal Medicine, Section of Allergology, Erasmus MC, Rotterdam, The Netherlands.
⁸² Member of the Brazilian Society of Pediatrics and Society of Immunization, Representative of GINA (Global Initiative Against Asthma), Brasilia, Brazil.
⁸³ Allergy Clinic, Hospital Regional del ISSSTE 'Lic. López Mateos', Mexico City, Mexico.
⁸⁴ Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
⁸⁵ University Hospital Olomouc - National eHealth Centre, Olomouk, Czech Republic.
⁸⁶ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
⁸⁷ Centich: centre d'expertise national des technologies de l'information et de la communication pour l'autonomie, Gérontopôle autonomie longévité des Pays de la Loire, Conseil régional des Pays de la Loire, Centre d'expertise Partenariat Européen d'Innovation pour un vieillissement actif et en bonne santé, Nantes, France.
⁸⁸ Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
⁸⁹ Alergologo, Ensenada, Mexico.
⁹⁰ Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
⁹¹ Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
⁹² Libra Foundation, Buenos Aires, Argentina.
⁹³ Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
⁹⁴ Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau (APHP, Paris), Paris, France.
⁹⁵ Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
⁹⁶ Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey.
⁹⁷ Immunology and Allergy Division, Department of Chest Diseases, School of Medicine, Hacettepe University, Ankara, Turkey.
⁹⁸ Allergy Centre, Tampere University Hospital, Tampere, Finland.
⁹⁹ Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
¹⁰⁰ GARD, Geneva, Switzerland.
¹⁰¹ Center for Rhinology and Allergology, Wiesbaden, Germany.
¹⁰² Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
¹⁰³ Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
¹⁰⁴ Department of Respiratory Medicine, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic.
¹⁰⁵ Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
¹⁰⁶ Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy.
¹⁰⁷ Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México City, Mexico.
¹⁰⁸ Presidente CMMC, Milano, Italy.
¹⁰⁹ Head of the Allergy Department of Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina.
¹¹⁰ Faculdade de Medicina da Universidade Federal da Bahia, Salvador de Bahia, Brazil.
¹¹¹ Sifmed, Milano, Italy.
¹¹² Promotor B3 Action GRoup EIP on AHA and Senior Fellow, International Foundation for Integreted Care, Aberystwyth, UK.
¹¹³ Tech Life Valley, Diepenbeek, Belgium.
¹¹⁴ Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
¹¹⁵ University of Guadalajara, Guadalara, Mexico.
¹¹⁶ Faculty of Medicine, Institute of Biomedical Imaging and Life Sciences (IBILI), University of Coimbra, Coimbra, Portugal.
¹¹⁷ Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
¹¹⁸ Argentine Association of Allergy and Clinical Immunology, Buenos Aires, Argentina.
¹¹⁹ Hospital Regional Siglo XXI, Mexico City, Mexico.
¹²⁰ Alergologo, Veracruz, Mexico.
¹²¹ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹²² CIRFF, Federico II University, Naples, Italy.
¹²³ Caisse d'assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR), Montpellier, France.
¹²⁴ Regione Piemonte, Torino, Italy.
¹²⁵ Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal.
¹²⁶ Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
¹²⁷ Laboratory of General Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
¹²⁸ Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
¹²⁹ Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
¹³⁰ Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy.
¹³¹ MedScript Ltd, Dundalk, Co. Louth, Ireland.
¹³² Consortium of Pharmacies and Services COSAFER, Salerno, Italy.
¹³³ Head of Respiratory Medicine, Alassia Children's Hospital, Center for Allergy and Immunology, Santa Fe, Argentina.
¹³⁴ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic., Australia.
¹³⁵ EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
¹³⁶ Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
¹³⁷ Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
¹³⁸ Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, Genoa, Italy.
¹³⁹ Department of Pneumology, CHU Grenoble, Grenoble, France.
¹⁴⁰ Allergy Unit, CUF-Porto Hospital and Institute, Center for Research in Health Technologies and Information Systems, CINTESIS, Universidade do Porto, Porto, Portugal.
¹⁴¹ Sociologist, Municipality, Sorrento, Italy.
¹⁴² Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
¹⁴³ Vice-Presidente of IML, Milano, Italy.
¹⁴⁴ Alergista, Recife, Brazil.
¹⁴⁵ Centre of Pneumology, Coimbra University Hospital, Coimbra, Portugal.
¹⁴⁶ Alergologo, Mexico City, Mexico.
¹⁴⁷ Medical University of Graz, Graz, Austria.
¹⁴⁸ Allergy Unit, Presidio Columbus, Rome, Catholic University of Sacred Heart, Rome, Italy.
¹⁴⁹ IRCCS Oasi Maria S.S., Troina, Italy.
¹⁵⁰ Association of Finnish Pharmacists, Helsinki, Finland.
¹⁵¹ Allergist, Vitoria, Brazil.
¹⁵² Departement of Internal Medicine, University Hospital, Olomouc, Czech Republic.
¹⁵³ IML (Lombardy Medical Initiative), Bergamo, Italy.
¹⁵⁴ Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
¹⁵⁵ Center for Life Course Health Research, Helsinki University Hospital, Helsinki University, University of Oulu, Oulu, Finland.
¹⁵⁶ Public Health Institute of Vilnius University, Vilnius, Lithuania.
¹⁵⁷ Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
¹⁵⁸ Department of ENT, Medical University of Graz, Graz, Austria.
¹⁵⁹ Division on Pharmacy and Devices Policy, Campania Region, Naples, Italy.
¹⁶⁰ Pneumology and Allergy Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
¹⁶¹ Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.
¹⁶² Allergy Clinic, Terveystalo, Turku, Finland.
¹⁶³ Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania.
¹⁶⁴ European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
¹⁶⁵ FILHA, Finnish Lung Association, Helsinki, Finland.
¹⁶⁶ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
¹⁶⁷ International Primary Care Respiratory Group IPCRG, Aberdeen, UK.
¹⁶⁸ Department of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
¹⁶⁹ EIP on AHA Coordinator, Region of Southern Denmark, Odense, Denmark.
¹⁷⁰ Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet and Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden.
¹⁷¹ Queen's University, Belfast, UK.
¹⁷² Celal Bayar University Department of Pulmonology, GARD Executive Committee, Manisa, Turkey.
¹⁷³ Universidad Católica de Córdoba, Córdoba, Argentina.
¹⁷⁴ Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
¹⁷⁵ EC-CNECT-H2, European Commission, Brussels, Belgium.

PMID: 28600902
DOI: 10.1111/all.13218

Abstract

The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) are to enable European citizens to lead healthy, active and independent lives whilst ageing. The EIP on AHA includes 74 Reference Sites. The aim of this study was to transfer innovation from an app developed by the MACVIA-France EIP on AHA reference site (Allergy Diary) to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (ICT) tools (i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve the understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will be: (i) to assess the percentage of adults and elderly who are able to use the Allergy Diary, (ii) to study the phenotypic characteristics and treatment over a 1-year period of rhinitis and asthma multimorbidity at baseline (cross-sectional study) and (iii) to follow-up using visual analogue scale (VAS). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults.

Keywords: Allergy Diary; Allergy; European Innovation Partnership on Active and Healthy Ageing; asthma; rhinitis.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

Affiliations

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

Authors

Affiliations

Abstract

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical